Benzinga | Aug 10, 2020 04:11PM EDT

Adaptive Biotechnologies Q2 EPS $(0.26) Beats $(0.28) Estimate, Sales $21.00M Beat $18.80M Estimate

Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.28) by 7.14 percent. This is a 78.86 percent increase over losses of $(1.23) per share from the same period last year. The company reported quarterly sales of $21.00 million which beat the analyst consensus estimate of $18.80 million by 11.70 percent. This is a 5.14 percent decrease over sales of $22.14 million the same period last year.